Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemisinin combination therapies for uncomplicated falciparum malaria in children in Gabon
PACTR202511868232388Phase 4Not yet recruiting
- Sponsor
- Centre de Recherches Médicales de Lambaréné
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of artemether, lumefantrine, pyronaridine and artesunate in malaria and Malaria (2 arms), sponsored by Centre de Recherches Médicales de Lambaréné. Primary endpoint: Treatment outcome classification. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
artemetherlumefantrinepyronaridineartesunate
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR202511868232388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511868232388.